RFK Jr. Spokesman Resigns Over Trump Administration’s Flavored E-Cigarette Policy 
Macron Faces Political Test Over Bank of France Nomination Ahead of 2027 Election 
US Adds European Union to Section 301 Watchlist Amid Trade Concerns 
Starmer Faces Leadership Crisis as Wes Streeting Reportedly Considers Challenge 
Intermittent fasting doesn’t have an edge for weight loss, but might still work for some 
U.S. Urges China to Help Curb Iran’s Actions in Gulf, Rubio Says 
Trump, Xi Begin High-Stakes China Summit Focused on Trade, Taiwan and Global Tensions 
Federal and State Authorities Conduct Widespread Fraud Raids Across Minnesota 
Eli Lilly and Insilico Medicine Forge $2.75 Billion AI-Driven Drug Discovery Deal 
Novo Nordisk Raises 2026 Outlook on Strong Wegovy Demand 
Dulles Airport Rebuild Plan Could Transform Washington’s Main International Gateway 
Saudi Arabia’s Secret Strikes on Iran Reveal Escalating Middle East Conflict 
Trump Administration Dismisses Entire National Science Board, Raising Concerns Over Scientific Independence 
Senate Stablecoin Bill Sparks Clash Between Banks and Crypto Industry 
Panama Defends Port Takeover Amid U.S.-China Tensions and Canal Dispute 
Daiichi Sankyo Stock Drops After Earnings Delay and Oncology Review 
U.S. Health Secretary Robert F. Kennedy Jr. told lawmakers this week that he is open to sharing details about David Geier’s contract with the Department of Health and Human Services (HHS), signaling growing scrutiny over the controversial appointment. During a Senate Finance Committee hearing, Kennedy stated that the contract could be provided to senators before the end of the week, offering what may become the first clear explanation of Geier’s responsibilities within the agency.
David Geier, known for his long-standing anti-vaccine activism, is currently working as a contractor tied to the Centers for Disease Control and Prevention (CDC). According to federal records, he is listed as a senior data analyst within the HHS system. His involvement has raised concerns among lawmakers and public health experts, particularly given his history of promoting debunked claims linking vaccines to autism.
Senator Ben Ray Luján of New Mexico pressed Kennedy on whether the administration would also release the protocols guiding Geier’s work. Kennedy responded that such protocols are not yet in place but promised they would be shared once the vaccine safety review is completed. Kennedy has previously indicated that Geier is leading a review of CDC vaccine data, a move that has sparked debate due to Geier’s controversial background.
Geier’s past actions have added to the concern. He was previously fined in Maryland for practicing medicine without a license and for administering unsafe treatments to children with autism. Critics argue that his involvement in federal health initiatives could undermine public trust in vaccine safety.
The situation highlights ongoing tensions around vaccine policy, public health transparency, and the role of individuals with disputed scientific views in government positions. As pressure builds, the release of Geier’s HHS contract could play a key role in shaping public and political response to the administration’s handling of vaccine-related issues.
